| Title | Authors (identified) | Published In | Identifier(s) | Topic | Published Date | Match? |
|---|
| Effect of Sharp Diameter Geometrical Modulation on the Magnetization Reversal of Bi-Segmented FeNi Nanowires | [1]Miguel Méndez, [2]Víctor Vega, [3]Silvia González, [4]Rafael Caballero-Flores, [5]Javier García, [6]Victor De La Prida [Full author list] | Nanomaterials [missing] | DOI: 10.3390/NANO8080595 [ORCID]
PubMed: 30081591 [ORCID]
| nanowire [missing] | 2018-08-05 | |
| Structure and sequence based functional annotation of Zika virus NS2b protein: Computational insights | [1]Daniel Aguilera-Pesantes, [1-Q89255013]Daniel Aguilera-Pesantes, [2]Miguel A. Méndez, [2-Q81041298]Miguel A Mendez [Full author list] | Biochemical and Biophysical Research Communications [missing] | DOI: 10.1016/J.BBRC.2017.02.035 [ORCID]
PubMed: 28188791 [ORCID]
| biophysics [missing]; cell biology [missing]; computational biology [missing]; Zika virus [missing]; congenital Zika virus infection [missing]; Zika virus proteome [missing] | 2017-02-08 | Miguel A Mendez (Q81041298; 5 items)
|
| Host stage suitability and impact of Encarsia noyesi (Hymenoptera: Aphelinidae) on the invasive rugose spiraling whitefly, Aleurodicus rugioperculatus (Hemiptera: Aleyrodidae), in Florida | [1]Anthony J. Boughton, [2]Miguel A. Mendez, [3]Antonio W. Francis, [4]Trevor R. Smith, [5]Lance S. Osborne, [6]Catharine M. Mannion [Full author list] | Biological Control [missing] | DOI: 10.1016/J.BIOCONTROL.2015.04.016 [ORCID]
| Hymenoptera [missing]; Hemiptera [missing]; invasive species [missing]; Aleyrodidae [missing]; Aleurodicus rugioperculatus [missing]; Aphelinidae [missing]; Encarsia noyesi [missing]; invasion impact [missing] | 2015-09-01 | |
| Evaluating Soil Threats Under Climate Change Scenarios in the Andalusia Region, Southern Spain | [1]María Anaya-Romero, [2]Sameh Kotb Abd-Elmabod, [3]Miriam Muñoz-Rojas, [4]Gianni Castellano, [5]Carlos Juan Ceacero, [6]Susana Alvarez, [7]Miguel Méndez, [8]Diego De la Rosa [Full author list] | Land Degradation and Development [missing] | DOI: 10.1002/LDR.2363 [ORCID]
| climate change [missing] | 2015-03-19 | |
| Enterocolitis, antimicrobials and hemolytic-uremic syndrome in children: Review of a concept | [1]Patricio Herrera, [2]Carlos Valenzuela, [3]Marcos Skarmeta, [4]Miguel Méndez, [5]Alvaro Bustos-González [Full author list] | Revista chilena de infectología [missing] | DOI: 10.4067/S0716-10182012000300010 [ORCID]
PubMed: 23096471 [ORCID]
| hemolytic-uremic syndrome [missing] | 2012-06-01 | |
| Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer | [1]Miguel Martín, [2]Alvaro Rodríguez-Lescure, [3]Amparo Ruiz, [4]Emilio Alba, [5]Lourdes Calvo, [6]Manuel Ruiz-Borrego, [7]Ana Santaballa, [8]César A Rodríguez, [9]Carmen Crespo, [10]Mar Abad, ..., [12]Jesús Florián, [13]Cristina Llorca, [14]Miguel Méndez, [15]María Godes, [16]Ricardo Cubedo, ... [Full author list] | Breast Cancer Research and Treatment [missing] | DOI: 10.1007/S10549-009-0663-Z [ORCID]
PubMed: 20037779 [ORCID]
| paclitaxel [missing] | 2010-08-01 | |
| Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study). | [1]Ignasi Tusquets, [2]Enrique Espinosa Arranz, [3]Miguel Méndez, [4]J Miquel Gil, [5]José Luis Guallar, [6]Núria Perulero, [7]PROSA Study investigators [Full author list] | Clinical and Translational Oncology [missing] | DOI: 10.1007/S12094-009-0344-8 [ORCID]
PubMed: 19380299 [ORCID]
| | 2009-04-01 | |
| A multicenter phase II study of irinotecan in patients with advanced colorectal cancer previously treated with 5-fluorouracil | [1]Miguel Méndez, [2]Antonieta Salut, [3]Carlos García-Girón, [4]Marta Navalon, [5]Pilar Diz, [6]Maria José García López, [7]Pilar España, [8]Ascensión de la Torre, [9]Purificación Martínez del Prado, [10]Isabel Duarte, [11]Eduardo Pujol, [12]Alberto Arizcun, [13]Juan Jesús Cruz [Full author list] | Clinical Colorectal Cancer [missing] | DOI: 10.3816/CCC.2003.N.023 [ORCID]
PubMed: 14706177 [ORCID]
| colorectal cancer [missing]; irinotecan [missing] | 2003-11-01 | |
| Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study | [1]Serafin Morales, [2]Antonio Lorenzo, [3]Manuel Ramos, [4]Pedro Ballesteros, [5]Miguel Méndez, [6]Concepción Almanza, [7]Javier Castellanos, [8]José Andrés Moreno-Nogueira, [9]Joaquín Casal, [10]José Lizón, [11]Amparo Oltra, [12]Adolfo Frau, [13]Ignacio Machengs, [14]Antonio Galán, [15]Joaquín Belón, [16]Cristina Llorca [Full author list] | Cancer Chemotherapy and Pharmacology [missing] | DOI: 10.1007/S00280-003-0690-0 [ORCID]
PubMed: 14557896 [ORCID]
| docetaxel [missing]; chemotherapy [missing]; metastatic breast cancer [missing] | 2003-10-14 | |
| People v. Ewoldt: The California Supreme Court's About-Face on the Plan Theory for Admitting Evidence of an Accused's Uncharged Misconduct | [0]Edward J. Imwinkelried, [1]Miguel A. Mendez [Full author list] | Loyola of Los Angeles Law Review [missing] | | law [missing] | 1995-01-01 | |